Northwire Canada EditionThursday, October 15, 2026
Northwire
⌕
GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4% GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4%
Earnings

Auxly Reports Fourth Quarter and Full Year 2025 Results

XLY · Price

Executive Summary

  • Auxly Cannabis Group reported FY 2025 net revenue of $151.5 M (+24% YoY) and Adjusted EBITDA of $43.8 M (+64% YoY), delivering a Material‑Positive earnings release.
  • Q4 2025 revenue reached $40.1 M (+16% YoY) with Adjusted EBITDA of $12.5 M, net income of $0.9 M and cash balance of $32.3 M; total debt to EBITDA improved to 1.1×.
  • Management announced a $10‑$12 M capital program for 2026 and disclosed that Auxly has become the DIP lender and stalking‑horse bidder for Ayurcann Inc.’s assets, indicating strategic M&A activity.

Key Details

  • FY 2025 Financial Highlights
  • Net revenue: $151.5 M (↑24%)
  • Gross Margin on Finished Cannabis Inventory Sold: 54% (↑8 pts)
  • Adjusted EBITDA: $43.8 M (↑64%) – margin 29%
  • Net income: $41.9 M (+356% YoY) → $0.03 per share
  • Cash & equivalents: $32.3 M (↑76% YoY)
  • Debt: $46.3 M (↓15% YoY); Debt/Adj‑EBITDA = 1.1×

  • Q4 2025 Financial Highlights

  • Net revenue: $40.1 M (↑16%)
  • Gross Margin on Finished Cannabis Inventory Sold: 56% (↑2 pts)
  • Adjusted EBITDA: $12.5 M (↑14%) – margin 31%
  • Net income: $0.9 M (+‑79% YoY due to fair‑value losses) → $0.001 per share
  • Cash at quarter end: $32.3 M

  • Operational Updates

  • Launched premium‑tier brand “South Point” in Alberta & Ontario.
  • Capital program for 2026: $10‑$12 M to upgrade Auxly Leamington facility and enable direct international shipments.

  • Strategic M&A Activity

  • Became DIP lender and stalking‑horse bidder for Ayurcann Inc.’s assets (vapes & pre‑rolls). Transaction size deemed conservative relative to cash position; aligns with growth strategy.

  • Outlook & Guidance

  • Continued focus on profitable growth in Canada, evaluating export opportunities, and allocating $10‑$12 M of operating cash flow to capital projects in 2026.

Notable Quotes

“Q4 2025 was a strong finish… we delivered 24% net revenue growth and 64% Adjusted EBITDA growth… Our balance sheet also strengthened materially… We are excited about the year ahead…” – Hugo Alves, CEO


All non‑material boilerplate, forward‑looking disclaimer text, and company background have been omitted.

Read the original news release →

More from AUXLY CANNABIS GROUP INC. J